African American race and HIV virological suppression: Beyond disparities in clinic attendance

American Journal of Epidemiology

Volumn 179, Issue 12, 2014, Pages 1484-1492

  Howe, Chanelle J ^a   Napravnik, Sonia ^b,c   Cole, Stephen R ^b   Kaufman, Jay S ^d   Adimora, Adaora A ^b,c   Elston, Beth ^a   Eron Jr , Joseph J ^c   Mugavero, Michael J ^e  

^a BROWN UNIVERSITY   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e University of Alabama at Birmingham   (United States)

Author keywords

clinic visits; cohort studies; health status disparities; human immunodeficiency virus; viral load

Indexed keywords

VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN AMERICAN; COHORT ANALYSIS; HEALTH RISK; HEALTH STATUS; HUMAN IMMUNODEFICIENCY VIRUS; RACIAL DISPARITY; SPATIOTEMPORAL ANALYSIS;

AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE DISPARITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; RACISM; UNITED STATES;

NORTH CAROLINA; UNITED STATES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

CLINIC VISITS; COHORT STUDIES; HEALTH STATUS DISPARITIES; HUMAN IMMUNODEFICIENCY VIRUS; VIRAL LOAD;

ADULT; AFRICAN AMERICANS; AMBULATORY CARE FACILITIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RNA, VIRAL; VIRAL LOAD;

EID: 84902532069     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu069     Document Type: Article

References (31)

1. Kissinger P, Cohen D, Brandon W, et al. Compliancewith public sector HIV medical care. J Natl Med Assoc. 1995;87(1): 19-24.
2. Catz SL, McClure JB, Jones GN, et al. Predictors of outpatient medical appointment attendance among persons with HIV. AIDS Care. 1999;11(3): 361-373.
3. Israelski D, Gore-Felton C, Power R, et al. Sociodemographic characteristics associated with medical appointment adherence among HIV-seropositive patients seeking treatment in a county outpatient facility. Prev Med. 2001;33(5): 470-475.
4. Mugavero MJ, Lin HY, Allison JJ, et al. Racial disparities in HIV virologic failure: Do missed visits matter? J Acquir Immune Defic Syndr. 2009;50(1): 100-108.
5. Gulick RM, Ribaudo HJ, Shikuma CM, et al. Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial. JAMA. 2006; 296(7): 769-781.
6. Mugavero MJ, Davila JA, Nevin CR, et al. From access to engagement: measuring retention in outpatient HIV clinical care. AIDS Patient Care STDS. 2010;24(10): 607-613.
7. Mugavero MJ, Westfall AO, Zinski A, et al. Measuring retention in HIV care: the elusive gold standard. J Acquir Immune Defic Syndr. 2012;61(5): 574-580.
8. VanderWeele TJ. Marginal structural models for the estimation of direct and indirect effects. Epidemiology. 2009;20(1): 18-26.
9. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5): 550-560.
10. Hafeman DM, Schwartz S. Opening the Black Box: a motivation for the assessment of mediation. Int J Epidemiol. 2009;38(3): 838-845.
11. Valeri L, Vanderweele TJ. Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods. 2013;18(2): 137-150.
12. Howe CJ, Cole SR, Napravnik S, et al. Enrollment, retention, and visit attendance in the University of North Carolina Center for AIDS Research HIV clinical cohort, 2001-2007. AIDS Res Hum Retroviruses. 2010;26(8): 875-881.
13. Hernán MA, Hernández-Díaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004;15(5): 615-625.
14. Jones CP. Invited commentary: "race," racism, and the practice of epidemiology. Am J Epidemiol. 2001;154(4): 299-304.
15. Andersen RM. Revisiting the behavioral model and access to medical care: Does it matter? J Health Soc Behav. 1995;36(1): 1-10.
16. Valdez H, Lederman MM, Woolley I, et al. Human immunodeficiency virus 1 protease inhibitors in clinical practice: predictors of virological outcome. Arch Intern Med. 1999;159(15): 1771-1776.
17. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999;131(2): 81-87.
18. Messeri PA, Abramson DM, Aidala African American, et al. The impact of ancillary HIV services on engagement in medical care in New York City. AIDS Care. 2002;14(suppl 1): S15-S29.
19. Rastegar DA, Fingerhood MI, Jasinski DR. Highly active antiretroviral therapy outcomes in a primary care clinic. AIDS Care. 2003;15(2): 231-237.
20. Cargill VA, Stone VE. HIV/AIDS: a minority health issue. Med Clin North Am. 2005;89(4): 895-912.
21. Robbins GK, Daniels B, Zheng H, et al. Predictors of antiretroviral treatment failure in an urban HIV clinic. J Acquir Immune Defic Syndr. 2007;44(1): 30-37.
22. Robbins GK, Johnson KL, Chang Y, et al. Predicting virologic failure in an HIV clinic. Clin Infect Dis. 2010;50(5): 779-786.
23. Mugavero MJ, Lin HY, Willig JH, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009;48(2): 248-256.
24. Zou GY, Donner A. Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res. 2013;22(6): 661-670.
25. Suzuki E, Evans D, Chaix B, et al. On the "proportion eliminated" for risk differences versus excess relative risks. Epidemiology. 2014;25(2): 309-10.
26. Hernán MA, Hernández-Díaz S, Werler MM, et al. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol. 2002;155(2): 176-184.
27. Hernán MA, McAdams M, McGrath N, et al. Observation plans in longitudinal studies with time-varying treatments. Stat Methods Med Res. 2009;18(1): 27-52.
28. VanderWeele TJ. Bias formulas for sensitivity analysis for direct and indirect effects. Epidemiology. 2010;21(4): 540-551.
29. Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168(6): 656-664.
30. Miettinen OS, Cook EF. Confounding: essence and detection. Am J Epidemiol. 1981;114(4): 593-603.
31. Greenland S. Absence of confounding does not correspond to collapsibility of the rate ratio or rate difference. Epidemiology. 1996;7(5): 498-501.